Balthaser Kevin
Chief Financial Officer · 12 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-01 | ACRS | Aclaris Therapeutics, Inc. | Tax withholding | 677 | $2.87 | $1,942.99 | filing |
| 2026-03-01 | ACRS | Aclaris Therapeutics, Inc. | Option exercise | 2,375 | — | — | filing |
| 2026-02-03 | ACRS | Aclaris Therapeutics, Inc. | Tax withholding | 6,449 | $3.47 | $22,378.03 | filing |
| 2026-02-03 | ACRS | Aclaris Therapeutics, Inc. | Option exercise | 22,025 | — | — | filing |
| 2026-02-01 | ACRS | Aclaris Therapeutics, Inc. | Tax withholding | 4,984 | $3.51 | $17,493.84 | filing |
| 2026-02-01 | ACRS | Aclaris Therapeutics, Inc. | Option exercise | 14,750 | — | — | filing |
| 2026-01-02 | ACRS | Aclaris Therapeutics, Inc. | Tax withholding | 4,461 | $2.88 | $12,847.68 | filing |
| 2026-01-02 | ACRS | Aclaris Therapeutics, Inc. | Option exercise | 13,200 | — | — | filing |
| 2026-01-01 | ACRS | Aclaris Therapeutics, Inc. | Tax withholding | 2,250 | $3.01 | $6,772.50 | filing |
| 2026-01-01 | ACRS | Aclaris Therapeutics, Inc. | Option exercise | 7,500 | — | — | filing |
| 2025-12-31 | ACRS | Aclaris Therapeutics, Inc. | Tax withholding | 19,934 | $3.01 | $60,001.34 | filing |
| 2025-12-31 | ACRS | Aclaris Therapeutics, Inc. | Option exercise | 73,750 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.